Industry News
Linking gene expression and DNA methylation in single cells
1/12/2016
A new method by researchers in the UK and Belgium makes it possible to study the epigenome and transcriptome of a single cell at the same time.
Even after anti-androgen therapy, docetaxel remains useful in prostate cancer
1/12/2016
A study presented at the 2016 Genitourinary Cancers Symposium shows that 40 percent of patients with castration-resistant metastatic prostate cancer (mCRPC) treated with docetaxel following...
Future of lung treatment: Malaysian scientists join Harvard team creating safe, effective nano drugs
1/12/2016
Malaysian scientists are joining forces with Harvard University experts to help revolutionize the treatment of lung diseases -- the delivery of nanomedicine deep into places otherwise impossible to...
Inconsistency in measures of breast density
1/12/2016
Breast density makes a difference in terms of breast screening opportunities, but measures of breast density appear to be inconsistent, with up to 19% of women incorrectly defined.
Study demonstrates that early and accurate prediction of leukemia is possible
1/12/2016
McMaster University researchers have taken a giant leap in identifying the early stages of a deadly cancer and predicting how it will develop in individuals.
Significant regional variation in treatment for oesophageal cancer found in England
1/12/2016
New figures released today show that the treatment received by patients for oesophageal cancer, and its precursor condition Barrett's oesophagus, varies significantly across England.
In a comprehensive modeling study, researchers from UC Davis and other institutions have found that breast cancer screening with digital mammography poses only a small risk of radiation-induced...
Painkiller diclofenac tapped to become future cancer-killer
1/11/2016
Diclofenac, a common painkiller, has significant anti-cancer properties, according to researchers from the Repurposing Drugs in Oncology project.
Ovarian cancer with BRCA1 mutation may be treatable with arthritis drug
1/11/2016
Lab tests show that auranofin - normally used to treat rheumatoid arthritis - can cut survival of ovarian cancer cells that have low levels of the DNA repair protein BRCA1.
Ovarian cancer with BRCA1 mutation may be treatable with arthritis drug
1/11/2016
Lab tests show that auranofin - normally used to treat rheumatoid arthritis - can cut survival of ovarian cancer cells that have low levels of the DNA repair protein BRCA1.